Revolutionizing IVF Treatment with Pharmacogenomics & AI!
Garbha AI – PGX Panel is a cutting-edge genotyping test that supports personalized infertility treatment by integrating precision medicine with AI-driven analytics.
Why Choose Garbha AI - PGX Panel?
- Personalized Hormone Therapy: Tailors medication plans based on individual genetic profiles for optimized response.
- AI-Powered Treatment Recommendations Utilizes predictive algorithms to identify the most effective hormonal strategies.
- Higher IVF Success Rates:Minimizes trial-and-error in treatment planning, leading to improved clinical outcomes.
- Fast & Reliable Results:: Employs multiplex RT-PCR technology for high accuracy and efficiency.
- Optimized for the Indian Population:Includes population-specific genetic markers to enhance treatment relevance and success.
- Easy Sample Collection: Non-invasive collection via buccal swab or blood sample for patient comfort.
- Comprehensive Reports: Provides AI-enhanced, clinician-friendly insights to guide precise treatment decisions.
AI & Data - Driven Insights
- Predictive Oocyte Viability Modeling: AI-powered algorithms analyze morphological, cytoplasmic, and structural parameters to predict oocyte competence and developmental potential.
- Real-time Selection Optimization : Enables continuous assessment during retrieval or ICSI to identify the most viable oocytes for fertilization
- Enhanced Decision-Making: Data-backed insights support more precise and confident therapeutic decisions.
- Key Genetic Markers Analyzed: Includes comprehensive analysis of CYP3A4, ESR1 & ESR2, GNRHR, FSHR, AMH, PGR, LHCGR, CYP19A1, CYP2C19, and MTHFR genes critical to hormone metabolism, ovarian response, and fertility outcomes.
Who Can Benefit?
- Fertility Specialists : Offers customized hormone therapy and precision drug recommendations based on genetic profiles for optimal IVF success.
- Couples Undergoing IVF : Provides valuable insights into the ideal timing for embryo transfer, significantly improving the chances of a successful pregnancy.
- Embryologists : Leverages AI-supported data to assist in making well-informed decisions regarding the optimal implantation timing.
- Patients with Repeated Implantation Failure (RIF) : Identifies potential timing and receptivity issues, improving the success rates of future IVF cycles.
- Clinics Seeking Data-Driven Approaches : Integrates advanced diagnostic tools for more accurate, efficient, and personalized fertility treatments.
FAQ's
PGx helps understand how a patient’s genes influence response to fertility medications.
It allows personalized hormone dosing to improve ovarian response and reduce side effects.
No, it supports the doctor with genetic insights to make more precise choices.
Key genes related to hormone response like FSHR, LHCGR, ESR1, and others.
Yes, PGx typically uses a simple blood or saliva sample.
Results are generally available in 7–14 days depending on the lab workflow.
Yes, it is non-invasive and poses no physical risks.
It may improve ovarian response and treatment efficiency, which supports better outcomes.
Yes, patient genetic data is securely stored and protected.
Ideal for first-time IVF patients and those with previous failure
It analyzes your genetic profile to suggest the most suitable medication and dosage.
It interprets gene variants linked to hormone response and converts them into actionable treatment insights.
It provides data-driven dosing guidance to reduce trial-and-error in medication adjustments
Yes, it predicts sensitivity levels to help avoid overstimulation or low follicular growth.
Yes, it helps start with the most suitable protocol rather than experimenting across cycles.
It learns from past cycles and refines the stimulation approach for better efficiency.
No, it supports the clinician with precise recommendations while the doctor makes final decisions.
It combines hormone levels, age, ovarian reserve metrics, and genotype to create a unified response model.
Yes, all patient genetic data is encrypted and handled under strict privacy protocols.
Yes, genetic results remain valid and can be used across multiple treatment cycles.ous poor or unpredictable responses.